NealPChristiansenMDFACP

PubMed

• Sequential Organ Failure Assessment Score Grouping Should Not Be the Primary Determinant of Allocation of Ventilators During a Pandemic
  Neal P Christiansen> ;The Journal of Clinical Ethics. 2021 Jan 1
• I Have Cancer-Now What?
  Neal P. Christiansen> ;The Oncologist. 2020 Jun 1
• Re: "Putting an End to It!".
  Neal P Christiansen> ;Journal of the National Comprehensive Cancer Network. 2016 Jan 1
• 22 citations
  Association between African American race and outcomes in patients with nonmetastatic triple-negative breast cancer: a retrospective analysis by using results from the...
  Neal P. Christiansen, Lei Chen, James Gilmore, David Pechar, Stephen Szabo> ;Clinical Breast Cancer. 2012 Aug 1
• 20 citations
  Absenteeism and short-term disability associated with breast cancer
  Alex Z. Fu, Lei Chen, Sean D. Sullivan, Neal P. Christiansen> ;Breast Cancer Research and Treatment. 2011 May 13
• 45 citations
  Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma
  Asher A. Chanan-Khan, Ruben Niesvizky, Raymond J. Hohl, Todd M. Zimmerman, Neal P. Christiansen, Gary J. Schiller, Natalie S. Callander, John Lister, Martin M. Oken, S...> ;Leukemia & Lymphoma. 2009 Jul 1
• Use of growth factors associated with docetaxel and paclitaxel in patients with early-stage breast cancer in a community oncology center.
  Boklage SH, Chen L, Christiansen NP, Sullivan SD, Hay JW, Mullins CD> ;J. Clin. Oncol.. 2009-05-20
• Treatment patterns of docetaxel and paclitaxel in patients with early-stage breast cancer in a community oncology center.
  Tangirala M, Lei C, Joel H, Christiansen N, Sullivan S> ;J. Clin. Oncol.. 2009-05-20
• A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC).
  Batist G, Sawyer M, Gabrail N, Christiansen N, Marshall JL, Spigel DR, Louie A> ;J. Clin. Oncol.. 2008-05-20
• 19 citations
  Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial
  Joseph Treat, Philip Bonomi, Michael McCleod, Neal P. Christiansen, David M. Mintzer, Matthew J. Monberg, Z. Ye, Ruqin Chen, Coleman K. Obasaju> ;Lung Cancer. 2006 Jul 1
• A multi-center, open-label study to evaluate the safety and efficacy of pentostatin, cytoxan, and rituxan (PCR) in the treatment of previously untreated or treated, st...
  Mena RR, Christiansen NP, Nyman DW, Markan Y, Chowhan NM> ;J. Clin. Oncol.. 2006-06-20
• 15 citations
  Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first rem...
  Martin S. Tallman, Waleska S. Pérez, Hillard M. Lazarus, Robert Peter Gale, Richard T. Maziarz, Jacob M. Rowe, David I. Marks, Jean-Yves Cahn, Asad Bashey, Michael R. ...> ;Biology of Blood and Marrow Transplantation. 2006 Feb 1
• Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical...
  McCleod M, Treat J, Christiansen NP, Mintzer DM, Bonomi P, Bloss LP, Taylor L, Monberg MJ, Ye Z, Obasaju CK> ;J. Clin. Oncol.. 2005-06-01
• Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger regis...
  Kozloff M, Cohn A, Christiansen N, Flynn P, Kabbinavar F, Robles R, Ulcickas Yood M, Sarkar S, Hambleton J, Grothey A> ;J. Clin. Oncol.. 2005-06-01
• Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer.
  Treat J, McCleod M, Mintzer D, Christiansen N, Bonomi P, Monberg M, Taylor L, Obasaju C> ;J. Clin. Oncol.. 2004-07-15
• 41 citations
  Autologous transplantation for diffuse aggressive Non-Hodgkin lymphoma in first relapse or second remission
  Julie M. Vose, Douglas Rizzo, Jing Tao-Wu, James O. Armitage, Asad Bashey, Linda J. Burns, N. P. Christiansen, Cesar O. Freytes, Robert Peter Gale, John Gibson, Sergio...> ;Biology of Blood and Marrow Transplantation. 2004 Feb 1
• 23 citations
  Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
  Charles A. Linker, Paolo Anderlini, Roger H. Herzig, N. P. Christiansen, George Somlo, William I. Bensinger, Joseph W. Fay, Joseph P. Lynch, Lawrence T. Goodnough, Mar...> ;Biology of Blood and Marrow Transplantation. 2003 Jun 1
• 11 citations
  Epstein–Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation
  Kuang-Yueh Chiang, L. J. Hazlett, K. T. Godder, Sunil Abhyankar, N. P. Christiansen, F. van Rhee, Lee C, K Bridges, R. S. Parrish, Henslee-Downey Pj> ;Bone Marrow Transplantation. 2001 Dec 1
• 6 citations
  Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation.
  Shannon Y. DeRienzo, Kuang-Yueh Chiang, Wane M. O'Neal, K. Godder, Sunil Abhyankar, N. P. Christiansen, Kerry D. Bridges, P. Jean Henslee-Downey> ;Pharmacotherapy. 2000 Oct 1
• 33 citations
  Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outc...
  K. Godder, Linda J. Hazlett, SH Abhyankar, K. Y. Chiang, N. P. Christiansen, Kerry D. Bridges, Lee C, S.S. Geier, Karen S. Goon-Johnson, Adrian P. Gee, Pati Ar, Rudolp...> ;Journal of Clinical Oncology. 2000 May 9
• 419 citations
  Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical...
  Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka, Steven M. Devine, J. L. Klein, Daniel J. Weisdorf, Joseph W. Fay, Auayporn Nademanee, Joseph H. Antin, Nea...> ;Blood. 1998 Oct 1
• 5 citations
  Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
  Steven H. Bernstein, Joseph P. Fay, Neal P. Christiansen, Luis Pinero, Deven Shah, Margaret Stephan, Geoffrey P. Herzig> ;Clinical Cancer Research. 1997 Sep 1
• A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for ...
  Bernstein, S. H., Eaves, C. J., Herzig, R., Fay, J., Lynch, J., Phillips, G. L., Christiansen, N., Reece, D., Ericson, S., Stephan, M., Kovalsky, M., Hawkins, K., Rasm...> ;Br J Haematol. 1997 Dec
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
  Bernstein, S. H., Christiansen, N. P., Fay, J. P., Brown, R., Herzig, R., Frankel, S., Blumenson, L., Herzig, G. P.> ;Exp Hematol. 1996 Oct
• Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant Group.
  Herzig, R. H., Lynch, J., Christiansen, N. P., Fay, J. W., Davis, M. P., Herzig, G. P.> ;Semin Oncol. 1996 Apr
• Join now to see all

Journal Articles

• Re: �Putting an end to it!�  
  Christiansen NP, J Natl Compr Canc Netw, 1/1/2016
• Treatment patterns of metastatic triple-negative breast cancer in US community practice settings  
  Christiansen NP, Chen L, Chung H, Contemporary Oncology, 1/1/2012
• Cancer recurrence and survival in patients with early stage triple-negative breast cancer  
  Christiansen NP, Chen L, Gilmore J, Szabo S, Commun Oncol, 1/1/2012
• Phase III randomized study of dexamethaxone with or without oblimersen sodium for patients with advanced multiple myeloma  
  Chanan-Khan AA, Nievsvizky R, Hohl RJ, Zimmerman TM, Christiansen NP, Schiller GJ, Callander N, Lister J, Oken M, Jagannath S, Leuk Lymphoma, 1/1/2009
• Pancreatic carcinoma  
  Christiansen NP, J South Carolina Med Assoc, 1/1/2003
• Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: studies with blasts of leukaemic patients  
  D'Atri S, Piccioni D, Castellano A, Tuorto V, Franchi A, Lu K, Christiansen N, Frankel S, Rustum YM, Papa G, Mandelli F, Bonmassar E, Ann Oncol, 1/1/1995
• Immunologic status of patients in remission from Hodgkin's disease and disseminated malignancies  
  Shapiro CM, Beckmann E, Christiansen N, Bitran JD, Kozloff M, Billings AA, Telfer MC, Am J Med Science, 1/1/1987
• Join now to see all

Abstracts/Posters

• Costs of absenteeism and short-term disability associated with breast cancer to U.S. employers
  Sullivan SD, Fu AZ, Jhaveri M, Christiansen NP, J Clin Oncol, 1/1/2010
• Health care cost of breast cancer: A claims data analysis
  Fu AZ, Jhaveri M, Sullivan SD, Christiansen NP, J Clin Oncol, 1/1/2010
• Association of black race and outcomes in patients with nonmetastatic triple-negative breast cancer (TNBC): Results from a U.S. local oncology practice
  Feinberg BA, Chen L, Zhao L, Gilmore JW, Haislip S, Saleh MN, Sullivan SD, Christiansen NP, J Clin Oncol, 1/1/2010
• Cancer recurrence and survival in patients with early-stage triple-negative breast cancer in a U.S. local oncology practice
  Zhao L, Seal BS, Feinberg BA, Gilmore JW, Haislip S, Sullivan SD, Christiansen NP, J Clin Oncol, 1/1/2010
• Taxane use and neuropathy in early-stage breast cancer patients: Results from a U.S. community oncology center
  Volas-Redd GH, Chen L, Zhao L, Feinberg BA, Gilmore JW, Haislip S, Sullivan SD, Christiansen NP, J Clin Oncol, 1/1/2010
• Use of growth factors associated with docetaxel and paclitaxel in patients with early-stage breast cancer in a community oncology center
  Boklage SH, Chen L, N. P. Christiansen NP, Sullivan SD, Hay JW, Mullins CD, Feinberg BA, J Clin Oncol, 1/1/2009
• A multi-center, open-label study to evaluate the safety and efficacy of pentostatin, Cytoxan and Rituxan (PCR) in the treatment of previously untreated or treated, sta...
  Christiansen NP, Mena R, Markan Y, Pandit L, Proc Amer Soc Clin Oncol, 1/1/2007
• A multi-center, open-label study to evaluate the safety and efficacy of pentostatin, Cytoxan and Rituxan (PCR) in the treatment of previously untreated or treated, sta...
  Mena RR, Christiansen NP, Markan Y, Pandit L, Blood, 1/1/2007
• Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy for metastatic colorectal cancer: updated results from a large observational study i...
  Kozloff M, Cohn A, Christiansen N, Flynn P, Kabbinavar F, Robles R, Ulcickas-Yood M, Blanke C, Squier M, Grothey A, Gastrointestinal Cancers Symposium, 1/1/2006
• A multi-center, open-label study to evaluate the safety and efficacy of pentostatin, Cytoxan and Rituxan (PCR) in the treatment of previously untreated or treated, sta...
  Mena RR, Christiansen NP, Markan Y, Pandit L, Proc Amer Soc Clin Oncol, 1/1/2006
• A multi-center, open-label study to evaluate the safety and efficacy of pentostatin, Cytoxan and Rituxan (PCR) in the treatment of previously untreated or treated, bul...
  Mena RR, Christiansen NP, Markan Y, Pandit L, Blood, 1/1/2006
• Safety of bevacizumab (BV, Avastin) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC) � preliminary results from a la...
  Kozloff M, Cohn A, Christiansen N, Flynn P, Kabbinavar F, Robles R, Ulcickas Yood M, Sarkar S, Hambleton J, Grothey A, Proc Amer Soc Clinc Oncol, 1/1/2005
• Pemetrexed (p) plus gemcitabine (g) as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): a phase II clinical...
  McCleod M, Treat J, Christiansen NP, Mintzer DM, Bonomi P, Bloss LP, Taylor L, Monberg MJ, Ye Z, Obasaju CK, Proc Amer Soc Clinc Oncol, 1/1/2005
• Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer
  Treat J, McCleod M, Mintzer D, Christiansen N, Bonomi P, Monberg M, Taylor L, Obasaju C, Proc Amer Soc Clinc Oncol, 1/1/2004
• Randomized multicenter phase 3 trial of high-dose dexamethasone (dex) with or without oblimersen sodium (G3139: bcl-2 antisense; Genasense) for patients with advanced ...
  Alban A, Chanan-Khan, Niesvizky R, Hohl RJ, Zimmerman TM, Christiansen NP, Schiller GJ, Smith S, Frankel S, Blood, 1/1/2004
• GM-CSF enhances the anti-leukemic effect of partially mismatched related donor stem cell transplant
  Godder K, Adams S, Chiang KY, vanRhee F, Metha J, Bridges K, DiRienzo S, O�Neal W, Christiansen NP, Henslee-Downey PJ, Proc Amer Soc Clin Oncol, 1/1/2000
• Partially mismatched related donor (PMRD) is highly effective for patients with early leukemia
  Christiansen NP, Bridges K, Hazlett L, Abhyankar S, Chiang KY, Godder K, Lee C, Neglia W, Parrish R, Henslee-Downey PJ, Proc Amer Soc Clin Oncol, 1/1/1999
• Cardiac and pulmonary changes following partially mismatched related donor bone marrow transplant and correlations to functionality of patients
  Strange P, McGuirk JP, Christiansen NP, Godder K, Abhyankar S, Chiang KY, Hazlett L, Parrish R, Henslee-Downey PJ, Clin Res, 1/1/1998
• Extracorporal photopheresis (ECP) with UVADEX� for the treatment of chronic graft versus host disease (CGVHD)
  Abhyankar S, Godder K, Chiang KY, Christiansen NP, Brown J, DeRienzo S, O�Neal W, Henslee-Downey PJ, Experimental Hematology, 1/1/1998
• High-dose cytarabine and idarubicin (HDAC/IDA) is effective remission induction therapy for older de novo but not for secondary acute myeloid leukemia (AML) patients
  Baer MR, Pixley LA, Lawrence D, O'Loughlin KL, Adel-Razeq S, Block AW, Sait SNJ, Wetzler M, Christiansen NP, Frankel SR, Herzig GP, Bloomfield CD, Blood, 1/1/1998
• Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (alloBMT)
  Alam A, Baer M, Bernstein S, Bernstein Z, Christiansen NP, Czuczman M, Schriber J, Slack J, Tezcan H, Wetzler M, Cooper M, Milk B, Ford L, Herzig G, McCarthy P, Blood, 1/1/1997
• Partially mismatched related donor bone marrow transplant (PMRD BMT) for chronic myeloid leukemia (CML) in first chronic phase
  Abhyankar S, Christiansen N, Godder K, Chiang KY, McGuirk J, Lee C, Gee A, Parrish R, Hazlett L, Bridges K, Henslee-Downey PJ, Blood, 1/1/1997
• Thiotepa-associated cardiomyopathy during hematopoietic stem cell transplantation
  Alidina A, Baer M, Bernstein S, Bernstein Z, Christiansen NP, Czuczman M, Schriber J, Slack J, Spangenthal T, Tezcan H, Wetzler M, Milk B, Swinnich D, Ford L, Herzig G..., Blood, 1/1/1997
• A randomized phase II study of BB-10010; a variant of human macrophage inflammatory protein-1a (MIP-1a) for patients receiving high dose etoposide and cyclophosphamide...
  Bernstein SH, Eaves CJ, Herzig R, Fay J, Lynch J, Phillips GL, Christiansen NP, Reece D, Ericson S, Stephan M, Kovalsky M, Hawkins K, Rasmussen H, de Vos A, Herzig GP, Blood, 1/1/1997
• Peak exercise oxygen uptake is predictive of bone marrow transplant mortality
  Loewen GM, Christiansen, N, Travaglia P, Westney G, Herzig G, Chest, 1/1/1996
• Join now to see all